Cite
HARVARD Citation
Mina, R. et al. (2023). Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial. Lancet oncology. 24 (1), pp. 64-76. [Online].